FREDERICK, MD., Fugue announced it has closed an approximately $41 million Series D financing round, bringing the company's total funding to date to more than $75 million. Read More
OAKMONT, PA, Cereve, a privately-held health care company preparing to launch its FDA-cleared insomnia device, announced today the closing of a $38 million Series B round of financing. Read More
LA JOLLA, CA, Avidity Biosciences today announced the completion of a $16 million Series B financing round to support the development of its Antibody-siRNA Conjugate (ASC) platform. Read More
